FDA Panel OKs Pfizer Booster Shot for People 65 or Older, But Not Younger - The Jewish Voice
96.7 F
New York
Tuesday, August 9, 2022

FDA Panel OKs Pfizer Booster Shot for People 65 or Older, But Not Younger

- Advertisement -

Related Articles

-Advertisement-

Must read

By: Ernie Mundell

An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness.

According to The New York Times, that vote came after a near unanimous decision (16 to 2) by the same independent panel of experts that said no to booster shots for Americans younger than 65.

The recommendation against booster shots for younger adults is a setback for the Biden administration, which earlier in the summer had pledged a rollout of boosters to the general population by this coming Monday, Sept. 20.

FDA advisory committee decisions are not binding on the agency, but it usually does follow its advisors’ recommendations.

Following an official ruling by the FDA — expected sometime next week — the U.S. Centers for Disease Control and Prevention would meet to outline how any new doses should be used.

According to the Times, Dr. Peter Marks, the official who directs the FDA’s vaccine division, had urged panel members to not only focus on severe illnesses when making their decision, but also the power of boosters to perhaps slow infection rates.

The two votes come after a day of intense discussion and presentations from Pfizer, which has pushed hard for third booster shots, as well as officials at the CDC. The agency has conducted studies that suggest that the two doses of Pfizer vaccine that tens of millions of Americans have already received are still keeping recipients safely out of the hospital.

Panel members also heard testimony from Israeli experts. Israel began doling out booster shots to its already well-vaccinated population earlier this summer. The Israeli data appears to suggest that a third shot does give a significant boost to immunity from severe illness.

However, Dr. Sara Oliver of the CDC presented data that current doses are still protecting even the very old from serious COVID-19.

One study published Friday in a CDC journal tracked the vaccination histories of almost 3,700 American adults hospitalized from March through mid-August. It found that those who had received two doses of the Pfizer vaccine still maintained 88% protection against being hospitalized with COVID-19.

In the Israeli study, published Sept. 15 in the New England Journal of Medicine, more than one million Israelis aged 60 and older received a booster dose. The study found that they were much less likely to become infected soon after with the contagious Delta variant, achieving what Pfizer called “roughly 95% effectiveness.” It is not known how long that protection will last, however.

Another Israeli scientist pointed to data on 1.1 million people over the age of 60 in that country. Crunching the numbers, the data suggests that 12 days after their booster shots, rates of severe disease fell 20-fold among those who had received the third shot, compared to people who had not.

(www.HealthDayNews.com)

balance of natureDonate

Latest article

- Advertisement -
EnglishHebrew
Skip to content